1,452 results on '"Barrett, A. John"'
Search Results
2. Identification of novel HLA-restricted preferentially expressed antigen in melanoma peptides to facilitate off-the-shelf tumor-associated antigen-specific T-cell therapies
3. Portfolio of original compositions : music of possibility
4. Occurrence and Mitigation of Bacterial Regrowth in Stored Household Water in Eastern Coastal Madagascar.
5. Framingham Risk Score Is an Ineffective Screening Strategy for Coronary Heart Disease in Long-Term Allogeneic Hematopoietic Cell Transplant Survivors
6. A review of American lobster (Homarus americanus) records around the British Isles: 2012 to 2018
7. An Introduction to Bone Marrow Transplantation and Processing
8. Reductions in Children’s Blood Lead Levels from a Drinking-Water Intervention in Madagascar, Sub-Saharan Africa
9. Distinct Biomarker Profiles in Ex Vivo T Cell Depletion Graft Manipulation Strategies: CD34+ Selection versus CD3+/19+ Depletion in Matched Sibling Allogeneic Peripheral Blood Stem Cell Transplantation
10. Reprint of: Virus-Specific T Cells: Broadening Applicability
11. Virus-Specific T Cells: Broadening Applicability
12. The Development of Cognitive Schemata in Children (Birth to 12 Years Old) of Depressed Parents: A Review of the Literature.
13. It's 1968 (again) and 'the field' rises (again)
14. Cultures of pro-slavery : the political defence of the slave trade in Britain c.1787 to 1807
15. Ex vivo T-cell–depleted allogeneic stem cell transplantation for hematologic malignancies: The search for an optimum transplant T-cell dose and T-cell add-back strategy
16. National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Subsequent Neoplasms Working Group Report
17. Allogeneic and Autologous T cell Strategies to Enhance Targeting of Acute Myeloid Leukemias
18. Supplementary Figure S3 from Development of Engineered T Cells Expressing a Chimeric CD16-CD3ζ Receptor to Improve the Clinical Efficacy of Mogamulizumab Therapy Against Adult T-Cell Leukemia
19. Supplementary Tables 1 - 2 from Ultra Low-Dose IL-2 for GVHD Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation Mediates Expansion of Regulatory T Cells without Diminishing Antiviral and Antileukemic Activity
20. S1: supplementary table from Generation of Tumor Antigen-Specific T Cell Lines from Pediatric Patients with Acute Lymphoblastic Leukemia—Implications for Immunotherapy
21. Supplementary Figure 1 from Ultra Low-Dose IL-2 for GVHD Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation Mediates Expansion of Regulatory T Cells without Diminishing Antiviral and Antileukemic Activity
22. Supplementary Table S1 from Development of Engineered T Cells Expressing a Chimeric CD16-CD3ζ Receptor to Improve the Clinical Efficacy of Mogamulizumab Therapy Against Adult T-Cell Leukemia
23. Supplementary data: Figures S2-S8 from Generation of Tumor Antigen-Specific T Cell Lines from Pediatric Patients with Acute Lymphoblastic Leukemia—Implications for Immunotherapy
24. Organised responses to British Union of Fascist Mobilisation in South Lancashire, 1932-40
25. Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis
26. Discourse learning and acculturation
27. Quantitative activation suppression assay to evaluate human bone marrow–derived mesenchymal stromal cell potency
28. Convergence of Social Marketing and Engineering: A Lead Mitigation Study in Madagascar
29. The role of stem cell transplantation for chronic myelogenous leukemia in the 21st century
30. Long term maintenance of myeloid leukemic stem cells cultured with unrelated human mesenchymal stromal cells
31. British Journal of Haematology celebrates its 200th volume
32. Supplemental Material - Convergence of Social Marketing and Engineering: A Lead Mitigation Study in Madagascar
33. Safety Issues in MSC Therapy
34. Opportunities and limitations of natural killer cells as adoptive therapy for malignant disease
35. The clinical and financial burden of pre-emptive management of cytomegalovirus disease after allogeneic stem cell transplantation—implications for preventative treatment approaches
36. Repair of Impaired Pulmonary Function Is Possible in Very-Long-Term Allogeneic Stem Cell Transplantation Survivors
37. Genetically engineered fixed K562 cells: potent “off-the-shelf” antigen-presenting cells for generating virus-specific T cells
38. Strategies to Augment Graft-versus-Leukemia and -Lymphoma Effects
39. Contributors
40. CD34+ selection and the severity of oropharyngeal mucositis in total body irradiation-based allogeneic stem cell transplantation
41. Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study
42. Acquired RhD mosaicism identifies fibrotic transformation of thrombopoietin receptor‐mutated essential thrombocythemia
43. Bone marrow homing and engraftment of human hematopoietic stem and progenitor cells is mediated by a polarized membrane domain
44. Problem- versus Case-based Approaches in Teaching Medical Students about Eating Disorders: A Controlled Comparison.
45. Evolution of the donor T-cell repertoire in recipients in the second decade after allogeneic stem cell transplantation
46. T-cell immune responses to Wilms tumor 1 protein in myelodysplasia responsive to immunosuppressive therapy
47. Immune Reconstitution in Recipients of Photodepleted HLA-Identical Sibling Donor Stem Cell Transplantations: T Cell Subset Frequencies Predict Outcome
48. Alloreactivity Across HLA Barriers Is Mediated by Both Naïve and Antigen-Experienced T Cells
49. Strategies to Prevent EBV Reactivation and Posttransplant Lymphoproliferative Disorders (PTLD) after Allogeneic Stem Cell Transplantation in High-Risk Patients
50. Tumor vaccines and beyond
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.